Real-Time PCR, Digital PCR And End-Point PCR Market 2024 - By Size, Trends, Opportunities And Forecast To 2033

The real-time pcr, digital pcr and end-point pcr market size has grown strongly in recent years. It will grow from $35.11 billion in 2023 to $38.37 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to standardization of pcr protocols, role in personalized medicine, contribution to drug discovery and development, adoption in forensic and paternity testing..

The real-time pcr, digital pcr and end-point pcr market size is expected to see strong growth in the next few years. It will grow to $54.95 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to expansion of molecular diagnostics, growth in infectious disease testing, increasing demand for genetic testing, market penetration in research and forensics, rapid point-of-care pcr solutions.. Major trends in the forecast period include emergence of digital assays, multiplex pcr advancements, shift towards digital pcr technology, automation and high-throughput systems, miniaturization of pcr platforms..

Market Overview -
Real-time PCR (polymerase chain reaction), digital PCR, and endpoint PCR are different techniques in molecular biology and genetic analysis used to amplify and analyze DNA samples. Real-time polymerase chain reaction (PCR) is a laboratory technique to amplify and quantify DNA or RNA molecules. Digital PCR is the third generation of PCR that enables precise quantification by segregating a sample into numerous isolated compartments. Endpoint PCR, or conventional PCR, refers to a fundamental molecular biology technique used to amplify a specific DNA sequence from a sample. These PCR techniques are used in various clinical applications, such as bacteria detection, DNA fingerprinting, and genetic disorder diagnosis.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13296&type=smp

Elevated Prevalence Of Infectious Diseases Fueling Growth In The Real-Time Pcr, Digital Pcr, And End-Point Pcr Market
The increase in the incidence of infectious diseases is expected to propel the growth of the real-time PCR, digital PCR, and end-point PCR markets going forward. Infectious diseases refer to illnesses caused by the invasion and multiplication of pathogenic microorganisms, including bacteria, viruses, fungi, and parasites. Real-time PCR, digital PCR, and end-point PCR are utilized in infectious diseases to quantify specific pathogens or their genetic material, monitor disease progression, and rapidly diagnose infections such as HIV, hepatitis, respiratory viruses, and tuberculosis. For instance, in July 2023, according to UNAIDS, the Switzerland-based UN program dedicated to addressing the global HIV/AIDS epidemic, the global population living with HIV increased to 39 million in 2022, up 3.17% from 37.7 million in 2020. Moreover, there were approximately 1.3 million new HIV infections reported in 2022. Furthermore, in March 2023, according to the Centers for Disease Control and Prevention, a US-based national public health organization, in the United States, 8,300 cases of tuberculosis (TB) were reported in 2022, a rise from 7,874 cases in 2021. Therefore, the increase in the incidence of infectious diseases will drive the growth of the cephalosporin market.

Competitive Landscape -
Major companies operating in the real-time pcr, digital pcr and end-point pcr market report are F. Hoffmann La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Co., GE HealthCare Technologies Inc., Agilent Technologies Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Eppendorf Group, Promega Corporation, Meridian Bioscience Inc., Takara Bio Inc. , Cole-Parmer Instrument Company LLC, Bioneer Corporation, Enzo Life Sciences Inc., Analytik Jena AG , Fluidigm Corporation, Elitech Group SAS, Microsynth AG, Stilla Technologies SAS, HTG Molecular Diagnostics Inc., AITbiotech Pte Ltd., Bio Molecular Systems, JN Medsys Pte Ltd., Biomeme Inc.

Innovative Advances In Digital Pcr Technology Transforming The Real-Time Pcr Market
Major companies operating in the real-time PCR, digital PCR, and end-point PCR markets are developing innovative products using advanced technologies such as digital polymerase chain reaction (dPCR) technology to better understand the nature of a patient's cancer, genetic disease, or infection. Digital polymerase chain reaction (dPCR) technology is a biotechnological refinement of conventional polymerase chain reaction (PCR) methods that can directly quantify and clonally amplify nucleic acid strands, including DNA, cDNA, or RNA. For instance, in August 2022, Roche Diagnostics, a US-based manufacturer of medicines and medical devices, launched the next-generation digital PCR Digital LightCycler System for early detection and treatment of various chronic and genetic disorders. The system is designed to automate workflow and manage data, eliminating the need for external calculations, software, and processors. A combination of three nano well plate configurations, six advanced optical channels, and 5x concentrated DNA and RNA master mixes provides high sensitivity and precision. The Digital LightCycler System is a valuable addition to Roche's portfolio of diagnostic platforms, providing advanced technology, clinical applications, customization and flexibility, and workflow automation.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/real-time-pcr-digital-pcr-and-end-point-pcr-global-market-report

Key Segments -
The real-time pcr, digital pcr and end-point pcr market covered in this report is segmented -
1) By Product: Instruments, Consumables And Reagents, Software And Services
2) By Technology: Quantitative, End-Point Polymerase Chain Reaction (PCR), Digital
3) By Applications: Clinical, Research, Forensic, Other Applications
4) By End User: Hospital, Diagnostic Labs, Pharma, Biotech, Contract Research Organizations

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.